Legal Representation
Attorney
Alisa C. Simmons
USPTO Deadlines
Application History
40 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 13, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 13, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 21, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| May 21, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED |
| May 18, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 18, 2022 | EXT5 | S | SOU EXTENSION 5 FILED |
| Feb 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 4, 2022 | EXT4 | S | SOU EXTENSION 4 FILED |
| Feb 4, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Dec 1, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Jul 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 26, 2021 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jul 26, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Oct 7, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 5, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 5, 2020 | EXT2 | S | SOU EXTENSION 2 FILED |
| Oct 5, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 6, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 4, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 4, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
| Aug 4, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 4, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 10, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 10, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 20, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 4, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Nov 1, 2019 | ALIE | A | ASSIGNED TO LIE |
| Oct 26, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 24, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 22, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 22, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 27, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 27, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 27, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 27, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 19, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations; medicated preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005